Comments
U.S. court revives KV Pharmaceutical investor suit
05.06.2012. | (Reuters) - Investors can continue to bring claims against KV Pharmaceutical Co for making false or misleading statements to the U.S. Food and Drug Administration, a federal appeals court ruled on Monday....
